Internal medicine

Liver disease

Alcoholic liver disease

Hepatocellular carcinoma

Disease

Gastroenterology

Intensive care medicine

Cirrhosis

Steatohepatitis

Fatty liver

Liver transplantation

Transplantation

Medicine

Journal of Hepatology

As the epidemics of obesity and type 2 diabetes mellitus increase worldwide, the prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing proportionately. The subtype of NAFLD which can be characterised as non-alcoholic steatohepatitis (NASH) is a potentially progressive liver disease that can lead to cirrhosis, hepatocellular carcinoma, liver transplantation, and death. NAFLD is also associated with extrahepatic manifestations such as chronic kidney disease, cardiovascular disease and sleep apnoea.

Non-alcoholic fatty liver disease – A global public health perspective